2024-07-10 16:08:19
(ANSA) – ROME, JULY 10 – 65% of patients would use a digital therapy proposed by their doctor, especially if it allowed them to improve their lifestyle and health status (77%) and have greater awareness of their pathology (72%). Within 5 years, artificial intelligence will revolutionize personalized medicine. These are some data from the research of the Life Science Innovation Observatory of the School of Management of the Milan Polytechnic, in collaboration with Alleanza Malattie Rare, Apmarr, Fand, FederAsma and Onconauti. Already today – the research explains – there are digital tools for home monitoring of the patient, such as sensors, health apps and real-world data, soon there will be AI applied to personalized medicine and the so-called digital therapies (DTx), “clinically validated digital solutions to integrate or replace traditional therapies, for which in Italy there is not yet a reference regulation”.
About half of the medical specialists involved in the research thanks to Consulcesi Homnya, Amd, Ame, Fadoi and Simfer, and of the general practitioners, involved thanks to Fimmg, would be willing to prescribe a digital therapy if they had the possibility, especially if they were certain that the patient possesses the digital skills for correct use (72% of medical specialists and 69% of GPs). Among the main benefits recognized by medical specialists, the possibility of having a greater number of data available to support both clinical research (68%) and to make decisions (65%) emerges.
At an international level, the Life Science Observatory has identified 93 digital therapies already present: 37% in psychiatry, 14% in endocrinology, 10% in rheumatology and 10% in oncology. The average price of a 90-day treatment is around 500 euros. The analysis also shows that for pharma, biotech and medtech companies “the barriers to investing in digital are above all the difficulty in quantifying the benefits deriving from investments and the lack of digital skills”.
(ANSA).
2024-07-10 16:08:19